Background: Pain is the most common complication of orthodontic treatment. Low-level laser therapy (LLLT) has been suggested as a new analgesic treatment free of the adverse effects of analgesic medications. However, it is not studied thoroughly, and the available studies are quite controversial. Moreover, helium neon (He-Ne) laser has not been assessed before.

Methods: This split-mouth placebo-controlled randomized clinical trial was performed on 16 male and 14 female orthodontic patients requiring bilateral upper canine retraction. The study was performed at a private clinic in Sari, Iran, in 2014. It was single blind: patients, orthodontist, and personnel were blinded of the allocations, but the laser operator (periodontist) was not blinded. Once canine retractor was activated, a randomly selected maxillary quarter received a single dose of He-Ne laser irradiation (632.8 nm, 10 mw, 6 j/cm(2) density). The other quarter served as the placebo side, treated by the same device but powered off. In the first, second, fourth, and seventh days, blinded patients rated their pain sensed on each side at home using visual analog scale (VAS) questionnaires. There was no harm identified during or after the study. Pain changes were analyzed using two- and one-way repeated-measures ANOVA, Bonferroni, and t-test (α = 0.01, β > 0.99). This trial was not registered. It was self-funded by the authors.

Results: Sixteen males and 11 females remained in the study (aged 12-21). Average pain scores sensed in all 4 intervals on control and laser sides were 4.06 ± 2.85 and 2.35 ± 1.77, respectively (t-test P < 0.0001). One-way ANOVA showed significant pain declines over time, in each group (P < 0.0001). Two-way ANOVA showed significant effects for LLLT (P < 0.0001) and time (P = <0.0001).

Conclusions: Single-dose He-Ne laser therapy might reduce orthodontic pain caused by retracting maxillary canines.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883614PMC
http://dx.doi.org/10.1186/s40510-015-0102-0DOI Listing

Publication Analysis

Top Keywords

laser irradiation
8
placebo-controlled randomized
8
randomized clinical
8
clinical trial
8
he-ne laser
8
laser
6
pain
6
single-dose low-level
4
low-level helium-neon
4
helium-neon laser
4

Similar Publications

Ultraelastic Lead Halide Perovskite Films via Direct Laser Patterning.

ACS Nano

January 2025

College of Materials and Chemistry & Chemical Engineering, Nuclear Technology Key Laboratory of Earth Science, Chengdu University of Technology, Chengdu 610059, China.

The precise patterning of elastic semiconductors holds encouraging prospects for unlocking functionalities and broadening the scope of optoelectronic applications. Here, perovskite films with notable elasticity capable of stretching over 250% are successfully fabricated by using a continuous-wave (CW) laser-patterning technique. Under CW laser irradiation, perovskite nanoparticles (NPs) undergo meticulous crystallization within the thermoplastic polyurethane (TPU) matrix, which yields the capability of an unparalleled stretch behavior.

View Article and Find Full Text PDF

The objective of this study was to perform a systematic review of the literature to determine the overall efficacy of low-level laser therapy (LLLT) in managing burning mouth syndrome (BMS). A literature search was conducted through PubMed, Scopus, Web of Sciences, and Cochrane Central Register of Controlled Trials from their inception up to 28 March 2023. The search terms were defined by combining (Mesh Terms OR Key Words) from "Burning mouth syndrome" AND (Mesh Terms OR Key Words) from "Laser therapy".

View Article and Find Full Text PDF

Triple-action cancer therapy using laser-activated NO-releasing metallomicellar nanophotosensitizer for pyroptosis-driven immune reprogramming.

J Control Release

January 2025

Department of Biomedical Sciences and BioMedical Sciences Graduate Program (BMSGP), Chonnam National University Medical School, Gwangju 61469, Republic of Korea; DR Cure Inc., Hwasun 58128, Republic of Korea. Electronic address:

Cancer photoimmunotherapy represents an intelligent and highly efficient therapeutic approach that harnesses the photothermal effect to precisely target and ablate tumor tissues, while simultaneously modulating the immune system to achieve tumor elimination. The integration of multifunctional therapeutic modalities for combined photoimmunotherapy requires advanced drug delivery systems. However, the design of a single nanoagent capable of serving as a multifunctional nanophotosensitizer remains a significant challenge.

View Article and Find Full Text PDF

Aggregated gold nanoparticles as photoactivators for the photopolymerization of proteins.

J Photochem Photobiol B

January 2025

Department of Chemistry, Susquehanna University, 514 University Avenue, Selinsgrove, PA 17870, USA. Electronic address:

Photopolymerization of bovine serum albumin was carried out using reactive oxygen species (ROS) generated by the irradiation of citrate-stabilized gold nanoparticles by a pulsed Nd:YAG laser. The ROS in this case, singlet oxygen (O), targets aromatic amino acids within the protein to induce photopolymerization or crosslinking. Other ROS, like the hydroxyl radical, can also form in solution and under high-energy irradiation.

View Article and Find Full Text PDF

Multifunctional metal-organic frameworks with photothermal-triggered nitric oxide release for gas/photothermal synergistic cancer therapy.

J Colloid Interface Sci

January 2025

Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing 210008 China. Electronic address:

Photothermal therapy (PTT) utilizing cyanine dyes (Cy) and nitric oxide (NO) gas therapy via BNN6 have demonstrated significant potential in cancer treatment. However, the rapid clearance of these small molecules from the body limits their accumulation at tumor sites, thereby reducing therapeutic efficacy. To address this, we employed the acid-sensitive nanomaterial ZIF-8 as a carrier to encapsulate Cy and BNN6, creating functionalized BNN6-Cy@ZIF-8 Nanoparticles (B-C@Z NPs) for the targeted delivery and release of Cy and BNN6 at tumor sites.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!